ABOUT / Regulatory status
Product development status
Our innovative breath-based cancer detection test is constantly under development and validation and has shown promising results in a large-scale observational clinical trial.
The SpotitEarly tests have not been approved yet by the Food and Drug Administration (FDA) and are currently under development and validation.
We are actively pursuing regulatory approval to bring this solution to a commercial phase.
Our follow-up clinical studies, the Pink study and the White study, offer additional substantial clinical validation for the product and method we employ. These meticulously designed and executed studies build upon the foundation of our initial research, further solidifying the efficacy and safety of our product.
Our CLIA-registered laboratory is equipped with state-of-the-art technology and staffed by highly trained and experienced professionals. We follow strict protocols to ensure that our tests are performed accurately and reliably.
We at SpotitEarly are committed to saving lives and improving clinical outcomes for everyone, everywhere.
We at SpotitEarly
are committed to saving lives and improving clinical outcomes
for everyone
everywhere
We at SpotitEarly are committed to saving lives and improving clinical outcomes for everyone, everywhere.
Our Values
Why can’t all people around the world adopt regular, hassle-free cancer pre-screening at home, and enjoy life to the fullest?
Currently, despite billions spent on cancer screening, nearly half of the cases are still not detected early enough.
Victory over cancer requires a fresh approach. We looked to nature, with its remarkable capabilities and resilience, and combined it with the power of artificial intelligence.
SpotitEarly’s technology allows more frequent testing of much wider audiences at a fraction of the cost.
We’re bringing the learning power embedded in our system to the forefront of the race against cancer.
Compassion
All humans deserve a better chance at life, and to be spared unnecessary suffering. We strive to preserve their dignity, independence and right to good health.
Accuracy
We uphold the highest standards of reliability, fundamental to our work. Precision and effectiveness in our solutions will lead to better outcomes for individuals.
Innovation
We continuously push the limits of technology to develop cutting-edge solutions for early detection. Only with disruption can we meet new challenges and deliver impactful results.
Canine Care
We truly care for our 4-legged partners’ wellbeing. We provide them the best nutrition, space to exercise, playtime, tons of love, warmth, and their favorite goodies.
FOUNDERS
Roi Ophir
Co-founder, Active Chairman
Jinni: Co founder, CPO & CMO
ArtToGet: Co founder & CEO
Ariel Ben-Dayan
Co-founder, CEO
K-9 unit: Formerly Commander
Hadassah MC: Board member
Ohad Sharon
Co-founder, CSO (Strategy)
Skilled entrepreneur, Senior Executive & High Rank Officer Special Units
Udi Bobrovsky
Co-founder, COO
SelfCare: Co-founder, VP products
MindSense: Co-founder, CEO
LEADERSHIP
Amir Lifshitz
VP of operations
BIOTECHNOLOGY
PRODUCT
CEO
CANINE OPERATION
Amir Lifshitz
VP of operations
BIOTECHNOLOGY
PRODUCT
CEO
Amir Lifshitz
VP of operations
Ari Taulo
Dog Caregiver
Ariel ben Dayan
CEO | Co-founder
Assaf Rabinowicz
CTO
David Levy
Dog Caregiver
Hilla Schaik-Harbour
Lead Regulation manager
Irit Gazit
Director of canine applied research
Itamar Wizegun
Trainer
Liya Schwartzbart
Dog Caregiver
Miia Levy
Lab Technician
Ohad Sharon
CSO | Co-founder
Omer Pinkas
Lab Technician
Reef Einoch Amor
Director of chemical analysis
Roi Ophir
Co-founder | Chairman
Roni Yakir
Office manager
Shlomi Madar
Director of business development NA
Udi Bobrovsky
COO
Vered Fogelman
Lab Technician
Yael Morgan
Head Trainer
Yarden Rosenthal
Lab Technician
Yossi Melamed
VP Canine operation
Zeev Hananis
Data analyst
Tom Birom
Dog Caregiver